May, 2024
May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO
May 2, 2024, 14:30

Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO

American Society of Clinical Oncology (ASCO) shared on X:

Breaking news from the ASCO Plenary Series:

Glecirasib demonstrates encouraging efficacy and safety in KRASG12C-mutated Non- Small Cell Lung Cancer (NSCLC) in phase 2 trial from China.

ASCO Daily News has more.”

Glecirasib

Source: ASCO/X